Skip to content

Questionnaire Survey on the User Experience of Sulprep and Niflec for Colonoscopy Preparation

Questionnaire Survey on the User Experience of Sulprep and Niflec for Colonoscopy Preparation - Questionnaire Survey on the User Experience of Sulprep and Niflec for Colonoscopy Preparation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000053527
Enrollment
120
Registered
2024-02-05
Start date
2024-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonoscopy

Interventions

None listed

Sponsors

Sendai city medical center Sendai open hospital, department of Gastroenteology, Yuta Shibuya.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Individuals who are considered to require colon polyp removal surgery following Total Colonoscopy with pre-procedural preparation using Sulprep at our outpatient center, followed by a subsequent two-night hospital stay. Participants who have provided consent for participation in the study via paper documentation. Individuals aged 18 years and older.

Exclusion criteria

Exclusion criteria: Exclude individuals who meet any of the following criteria Individuals with evident taste disorders. Individuals who have difficulty responding to questionnaires. Individuals with uncertain or unknown intake of laxatives or fluids, or those where uncertainty is anticipated. Individuals with allergies to the ingredients of Sulprep, Nifrec, or sodium picosulfate. Individuals unable to take the recommended dose of Sulprep. Individuals with lesions requiring procedures such as endoscopic submucosal dissection rather than typical polypectomy or mucosal resection. Patients with end-stage renal failure or undergoing dialysis. Patients in whom the cecum or anastomosis could not be reached during TCS. Patients in whom serious conditions such as advanced cancer were identified during TCS, aside from polyps suitable for removal. Patients who experienced serious adverse events during TCS. Patients with severe constipation planning to use methods other than the standard pre-procedural measures. Individuals deemed inappropriate by the attending physician.

Design outcomes

Primary

MeasureTime frame
The burden of pre-procedural preparation with Suprep compared to Niflec in surveys.

Secondary

MeasureTime frame
Ease of ingestion of the laxative, efficacy in bowel cleansing, volume of laxative and water intake, adverse events, etc., comparing Suprep and Niflec in surveys.

Countries

Japan

Contacts

Public ContactYuta Shibuya

Sendai city medical center Sendai open hospital department of Gastroenteology

you.s.together@openhp.or.jp0222521111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026